Schwickert A., Weghake E., Brüggemann K., Engbers A., Brinkmann B., Kemper B., Seggewiß J., Stock C., Ebnet K., Kiesel L., Riethmüller C., Götte M.
Research article (journal) | Peer reviewedMicroRNAs (miRNAs, micro ribonucleic acids) are pivotal post-transcriptional regulators of gene expression. These endogenous small non-coding RNAs play significant roles in tumorigenesis and tumor progression. miR-142-3p expression is dysregulated in several breast cancer subtypes. We aimed at investigating the role of miR-142-3p in breast cancer cell invasiveness. Supported by transcriptomic Affymetrix array analysis and confirmatory investigations at the mRNA and protein level, we demonstrate that overexpression of miR- 142-3p in MDA-MB-231, MDA-MB-468 and MCF-7 breast cancer cells leads to downregulation of WASL (Wiskott-Aldrich syndrome-like, protein: N-WASP), Integrin-αV, RAC1, and CFL2, molecules implicated in cytoskeletal regulation and cell motility. ROCK2, IL6ST, KLF4, PGRMC2 and ADCY9 were identified as additional targets in a subset of cell lines. Decreased Matrigel invasiveness was associated with the miR-142-3p-induced expression changes. Confocal immunofluorescence microscopy, nanoscale atomic force microscopy and digital holographic microscopy revealed a change in cell morphology as well as a reduced cell volume and size. A more cortical actin distribution and a loss of membrane protrusions were observed in cells overexpressing miR-142-3p. Luciferase activation assays confirmed direct miR-142-3p-dependent regulation of the 3'-untranslated region of ITGAV and WASL. siRNA-mediated depletion of ITGAV and WASL resulted in a significant reduction of cellular invasiveness, highlighting the contribution of these factors to the miRNAdependent invasion phenotype. While knockdown of WASL significantly reduced the number of membrane protrusions compared to controls, knockdown of ITGAV resulted in a decreased cell volume, indicating differential contributions of these factors to the miR-142-3p-induced phenotype. Our data identify WASL, ITGAV and several additional cytoskeleton- associated molecules as novel invasion-promoting targets of miR-142-3p in breast cancer.
Brinkmann, Benjamin Franz | FB05 - Faculty of Medicine (FB05) |
Ebnet, Klaus | Institute of Medical Biochemistry |
Götte, Martin | Department of Gynecology and Obstetrics |
Duration: 01/07/2015 - 30/06/2019 Funded by: EC H2020 - Marie Skłodowska-Curie Actions - Research and Innovation Staff Exchange Type of project: EU-project hosted at University of Münster | |
Duration: 01/07/2013 - 31/12/2014 Funded by: Federal Ministry of Research, Technology and Space Type of project: Participation in federally funded joint project |
MicroRNA miR–142–3p inhibits breast cancer cell invasiveness and stem cell properties by targeting integrin alpha V, KLF4 and multiple cytoskeletal elements Götte, Martin; (12/06/2016) 2nd Matrix Biology Europe Conference, Athen, Griechenland Type of talk: scientific talk | |
MicroRNA miR-142-3p regulates breast cancer cell invasiveness by synchronous targeting of integrin alpha V and multiple cytoskeletal elements Götte, Martin (16/11/2014) 2nd Workshop ‘Novel insights into Cancer Biology: New Targets and Therapeutic Approaches’, Kairo, Ägypten Type of talk: scientific talk | |
MicroRNA miR-142-3p inhibits breast cancer cell invasiveness: characterization of altered morphology and functional properties Götte, Martin (09/11/2014) 18th International Microscopy Congress, Prag, Tschechien Type of talk: scientific talk |
miR-142-3p, ein neuer Regulator der Invasivität und Motilität von MDA-MB-468-Mammakarzinomzellen Candidate: Schwickert, Alexander | Supervisors: Götte, Martin; Greve, Burkhard Period of time: until 01/07/2015 Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster |